Constantinos Kurt Wibmer
0000-0003-2329-2280
Publication & Citation Trends
Publications
0 total
Meet the author: Constantinos Kurt Wibmer
Cited by 0
Semantic Scholar
Defining the mechanism of cross-reactivity for a SARS-CoV-2 Beta-elicited antibody toward omicron sub-lineages.
Cited by 0
Semantic Scholar
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage OA
Cited by 30
Semantic Scholar
Exploiting V-Gene Bias for Rapid, High-Throughput Monoclonal Antibody Isolation from Horses OA
Cited by 2
Semantic Scholar
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa OA
Cited by 97
Semantic Scholar
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) OA
Cited by 104
Semantic Scholar
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge OA
Cited by 7
Semantic Scholar
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma OA
Cited by 1,168
Semantic Scholar
Detection of a SARS-CoV-2 variant of concern in South Africa OA
Cited by 1,490
Semantic Scholar
Research Topics
HIV Research and Treatment
(42)
HIV/AIDS drug development and treatment
(24)
SARS-CoV-2 and COVID-19 Research
(18)
Immune Cell Function and Interaction
(14)
Monoclonal and Polyclonal Antibodies Research
(11)
Affiliations
AstraZeneca (United Kingdom)
National Health Laboratory Service
Scripps Research Institute
National Institutes of Health
MACOM (United States)